Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation

PaperCitations, authors & open-access status

Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 338 citations, 2008 year and diamond oa status.

338
Citations
2008
Year
diamond
OA Status

Related on ScholarIQ

Yen‐Fu Chen
Author
Health Technology Assessment
Journal
Inflammatory mediators and NSAID effects
Topic
Inflammatory mediators and NSAID effects
Topic
Osteoarthritis Treatment and Mechanisms
Topic
Rheumatoid Arthritis Research and Therapies
Topic
470M+ articles · free account